|
Market Closed -
OTC Markets
20:04:58 21/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4903 USD | +7.76% |
|
+0.95% | +8.96% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.9M 1.79M 1.63M 3.05M 208M 3.05M 21.39M 8.24M 106M 8.17M 7.99M 343M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.75M 11.07M 10.08M 18.9M 1.29B 18.93M 133M 51.1M 658M 50.64M 49.52M 2.12B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | +7.76% | ||
| 1 week | +0.95% | ||
| Current month | +16.74% | ||
| 1 month | +8.96% | ||
| 3 months | +25.72% | ||
| 6 months | +57.65% | ||
| Current year | +8.96% |
| 1 week | 0.42 |  | 0.49 |
| 1 month | 0.35 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.23 | | 0.57 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.76% | +0.95% | +65.08% | -35.91% | 3.55M | |
| +1.04% | +2.34% | +54.91% | +111.75% | 1,038B | |
| -0.19% | +1.18% | +52.94% | +66.69% | 649B | |
| +0.20% | +1.04% | +18.88% | +72.38% | 467B | |
| +2.24% | +0.94% | +37.61% | +45.31% | 355B | |
| +0.90% | +1.95% | +18.79% | +25.27% | 269B | |
| +0.48% | +3.34% | +11.11% | +15.38% | 260B | |
| +1.95% | +3.06% | +37.75% | +45.93% | 213B | |
| -7.65% | -7.28% | -33.09% | -59.52% | 176B | |
| +0.30% | +2.83% | +31.97% | +100.03% | 187B | |
| Average | +0.79% | +0.94% | +29.60% | +38.73% | 361.51B | |
| Weighted average by Cap. | +0.60% | +1.47% | +35.87% | +65.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.12M 18.95M 17.25M 32.35M 2.21B 32.39M 227M 87.45M 1.13B 86.66M 84.74M 3.63B | 24.22M 21.11M 19.89M 18.11M 33.95M 2.32B 34M 238M 91.79M 1.18B 90.96M 88.94M 3.81B |
| Net income | -5.27M -4.59M -4.33M -3.94M -7.39M -505M -7.39M -51.8M -19.96M -257M -19.78M -19.35M -829M | -3.2M -2.79M -2.63M -2.4M -4.49M -307M -4.5M -31.5M -12.14M -156M -12.03M -11.76M -504M |
| Net Debt | 10.2M 8.89M 8.37M 7.63M 14.3M 977M 14.32M 100M 38.65M 498M 38.3M 37.45M 1.61B | 11.31M 9.86M 9.29M 8.46M 15.85M 1.08B 15.87M 111M 42.86M 552M 42.47M 41.53M 1.78B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/09/26 | $0.4903 | +7.76% | 10,073 |
| 17/09/26 | $0.4550 | -10.78% | 2,850 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
